Cargando…
Targeting Adenosine Receptor Signaling in Cancer Immunotherapy
The immune system plays a major role in the surveillance and control of malignant cells, with the presence of tumor infiltrating lymphocytes (TILs) correlating with better patient prognosis in multiple tumor types. The development of ‘checkpoint blockade’ and adoptive cellular therapy has revolution...
Autores principales: | Sek, Kevin, Mølck, Christina, Stewart, Gregory D., Kats, Lev, Darcy, Phillip K., Beavis, Paul A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6321150/ https://www.ncbi.nlm.nih.gov/pubmed/30513816 http://dx.doi.org/10.3390/ijms19123837 |
Ejemplares similares
-
CRISPR/Cas9 mediated deletion of the adenosine A2A receptor enhances CAR T cell efficacy
por: Giuffrida, Lauren, et al.
Publicado: (2021) -
Adenosine signaling: Optimal target for gastric cancer immunotherapy
por: Wang, Junqing, et al.
Publicado: (2022) -
Targeting adenosine for cancer immunotherapy
por: Leone, Robert D., et al.
Publicado: (2018) -
Switching on the green light for chimeric antigen receptor T‐cell therapy
por: Mardiana, Sherly, et al.
Publicado: (2019) -
Targeting Adenosine in Cancer Immunotherapy to Enhance T-Cell Function
por: Vigano, Selena, et al.
Publicado: (2019)